Toric IOL improves patient quality of life

Article

Implantation of a toric IOL results in improved patient quality of life and better visual, refractive and aberrometric results, states a new investigation.

Implantation of a toric IOL results in improved patient quality of life and better visual, refractive and aberrometric results, states a new investigation.

A team headed by Dr R. Mencucci, Department of Specialised Surgical Sciences–Eye Clinic, University of Florence, Florence, Italy, assessed three groups of subjects who underwent unilateral cataract surgery with IOL implantation.

The first group consisted of 40 patients with corneal astigmatism greater than 1.5 D implanted with an Acysof toric SN60TT IOL. Group two included 40 astigmatic patients implanted with the SN60AT IOL and group three included 40 patients with an astigmatism of less than 1.00 D implanted with an SB60AT IOL.

The outcome measures were uncorrected distance visual acuity (UDVA), refraction, lower order astigmatism, Strehl ratio and the modulation transfer function area ratio assessed over a three-month follow-up period. The group used a standardised quality of life test to assess both astigmatic groups three months postoperatively.

Postoperative UDVA and aberrometric values were significantly better in the toric and control group, compared with the SN60AT group. The mean postoperative spherical equivalent was significantly lower in the toric and control groups, compared to the SN60AT group.

Overall, the toric lens resulted in a better postoperative quality of life compared to the astigmatic SN60AT lens in astigmatic patients.

Please visit the British Journal of Ophthalmology to read the abstract.

Related Videos
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
A screenshot of Dr Filomena Ribeiro, president of the ESCRS
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
© 2024 MJH Life Sciences

All rights reserved.